Last year, the sales of construction machinery products declined significantly. In January-February this year, sales remained low. After eliminating the Spring Festival mismatch factors, sales of construction machinery were only slightly better than the seasonal pattern on a low base of January-February. In the first two months, sales of earth and rock machinery such as excavators, loaders and bulldozers declined by 47%, 32% and 19% respectively year-on-year, which was lower than expected. This was mainly due to factors such as destocking and gradual increase in the operating rate.
During the March-March period, sales of construction machinery increased month-on-month, and demand for excavator machines picked up. Downstream recovery started to improve in mid-to-late March. Although demand picked up in March, sales in the northern region remained weak year-on-year.
Affected by the expected real estate regulation, the overall construction machinery industry is still in a weak recovery phase, and the start-up, inventory, and capital chain risks have all been mitigated. However, with the implementation of the new round of real estate adjustment and control of the New Deal and the introduction of the eight countries and the implementation of specific rules, the investment in the property market is expected to cool down, it also means that real estate control has undergone substantial upgrading and will affect the demand for construction machinery.
The report released by Aegis Union Capital said recently that Europe, which is China's preferred destination for investment last year, will still show great investment attraction this year. China, which has 3.4 trillion foreign exchange reserves, also actively encourages companies to invest overseas, set up factories, and purchase technology to ensure the security of energy and commodity resources. Petri, co-founder and managing partner of Asia-Europe Union Capital, said that investment growth of 2-3 times the economic growth rate will be the mainstream trend, but the absolute number of investments is still very low.
China is currently the third largest foreign investor in the world, followed by the United States and Japan. In 2011, China ranked 16th. Last year, Chinese enterprises invested 77.2 billion U.S. dollars in foreign investment, an increase of 14%, of which mergers and acquisitions were 37.8 billion U.S. dollars, accounting for 49% of all foreign investment. In 2011, this figure was 44%.
According to data from Asia-Europe Union Capital, the spending of mainland Chinese companies in Europe rose by 21% last year, and investment in the United States rose by 48%, of which 14% was for mergers and acquisitions. In Asia, spending fell by 65%.
From the above situation, China's construction machinery companies will continue to face challenges in the future, investment and development need to be cautious.
Attenuated Vaccines (Live)
Influenza Vaccine, Live, Nasal, Freeze-dried is a cooperative project with the WHO, which has been included in Global Action Plan for Influenza Vaccines (GAP)[1]. Hundreds of millions of doses have been used in the world, and Changchun BCHT Biotechnology Co. has the exclusive right of production and
operation in China.
Intranasal spray administration, no injection and no pain
The vaccine is inoculated by nasal spray, equipped with nasal spray device, and only needs to spray once a year in two nostrils to prevent influenza.
Mucosal immunity + Cellular immunity + Humoral immunity
After influenza virus attacks human body, it widely exists in nasal cavity, respiratory tract and other mucosal parts, as well as in body fluids and cells.
Vaccination of Influenza Vaccine, Live, Nasal, Freeze-dried can quickly stimulate the triple immune response of human body, and carry out defense
against viruses in different parts:
·Intranasal administration can produce mucosal immunity (IgA antibody), which forms the first immune defense line in the nasal cavity.
·Produce humoral immunity (IgG antibody) to remove influenza virus from body fluids.
·Produce cellular immunity (T cells) to remove influenza virus from cells
3+N More extensive protection
The production strains are recommended and supplied by the WHO every year.
The vaccine can not only effectively resist the vaccine strain, but also produce cross immunity to other subtypes of influenza virus.
Produced with SPF embryonated eggs
SPF
The chick embryos for vaccine production comes from SPF (specific pathogen free) chicken flocks, so the risk of exogenous pathogenic microorganism
pollution is excluded.
Free of inactivator, split agent and preservative
High protection and fast antibody production
This is the first influenza vaccine in China that has been evaluated by the protection effect of etiology in clinical stage. The protective effect of phase III
clinical trial is consistent with the literature.
First, the immune barrier was formed in the nasal mucosa after LAIV vaccination. It has been reported that the antibody of nasal mucosa can be
produced in 3 days, which greatly shortens the time for vaccine to produce
protective effect.
Attenuated Vaccine, Live from BCHT, WHO GAP
Changchun BCHT Biotechnology Co. , https://www.ccbcht.net